Literature DB >> 23402112

Efficacy of rHVT-AI vector vaccine in broilers with passive immunity against challenge with two antigenically divergent Egyptian clade 2.2.1 HPAI H5N1 strains.

F Rauw1, V Palya, Y Gardin, T Tatar-Kis, K Moore Dorsey, B Lambrecht, T van den Berg.   

Abstract

In countries where avian influenza has become endemic, early vaccination of layer pullets or broilers with classical inactivated vaccines at the hatchery is no longer an option because of interference with passive immunity indirectly induced by the necessary vaccination of the breeders. On the other hand, injection of thousands of chicks from 7 to 10 days old on farms has been determined to be unreliable and, therefore, poorly efficacious. For these reasons, interest has arisen regarding a newly developed live recombinant vector vaccine based on a turkey herpesvirus (HVT) expressing the H5 gene from a clade 2.2 H5N1 highly pathogenic avian influenza virus (HPAIV) strain (rHVT-H5), which in theory is capable of breakthrough passive immunity to both the vector (HVT) and the insert (H5) and is consequently applicable at the hatchery. The objectives of this trial were to evaluate the impact of maternally derived antibodies (MDAs) specific to H5N1 on the immunity and the efficacy (protection and virus shedding) of different vaccination programs including rHVT-H5 and inactivated H5N1 and H5N2 vaccines applied alone or in combination. Therefore, broilers carrying MDAs against both HVT and Asian H5N1 HPAIV were vaccinated on the first day of age with rHVT-H5, with or without boosting vaccination by an inactivated vaccine after 10 days. The different groups were challenged with two antigenically highly divergent Egyptian dade 2.2.1 H5N1 HPAIVs at 4 wk of age. Protection against challenge was compared with unvaccinated birds or vaccinated birds without MDAs. Between 70% and 90% clinical protection could be observed in the vaccinated groups possessing MDAs, indicating no or very low interference of MDAs with vaccination. Results regarding clinical protection, humoral, cell-mediated, and mucosal immunity, as well as re-excretion of challenge virus are presented and discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23402112     DOI: 10.1637/10172-041012-Reg.1

Source DB:  PubMed          Journal:  Avian Dis        ISSN: 0005-2086            Impact factor:   1.577


  8 in total

1.  Effectiveness of different avian influenza (H5) vaccination regimens in layer chickens on the humoral immune response and interferon-alpha signalling immune marker.

Authors:  Mustafa Hamad; Omar Amen; Mohamed Mahmoud; Ola Hassanin; Mostafa Saif-Edin
Journal:  Vet Res Commun       Date:  2018-04-04       Impact factor: 2.459

2.  Immunogenicity and efficacy of fowlpox-vectored and inactivated avian influenza vaccines alone or in a prime-boost schedule in chickens with maternal antibodies.

Authors:  Alexandra Richard-Mazet; Sylvain Goutebroze; François-Xavier Le Gros; David E Swayne; Michel Bublot
Journal:  Vet Res       Date:  2014-10-30       Impact factor: 3.683

3.  Protective Efficacy of Recombinant Turkey Herpes Virus (rHVT-H5) and Inactivated H5N1 Vaccines in Commercial Mulard Ducks against the Highly Pathogenic Avian Influenza (HPAI) H5N1 Clade 2.2.1 Virus.

Authors:  Walid H Kilany; Marwa Safwat; Samy M Mohammed; Abdullah Salim; Folorunso Oludayo Fasina; Olubunmi G Fasanmi; Azhar G Shalaby; Gwenaelle Dauphin; Mohammed K Hassan; Juan Lubroth; Yilma M Jobre
Journal:  PLoS One       Date:  2016-06-15       Impact factor: 3.240

4.  Visualization of Alternative Functional Configurations of Influenza Virus Hemagglutinin Facilitates Rapid Selection of Complementing Vaccines in Emergency Situations.

Authors:  Ashraf Metwally; Ausama Yousif
Journal:  Int J Mol Sci       Date:  2017-04-04       Impact factor: 5.923

Review 5.  Innovation in Newcastle Disease Virus Vectored Avian Influenza Vaccines.

Authors:  Shin-Hee Kim; Siba K Samal
Journal:  Viruses       Date:  2019-03-26       Impact factor: 5.048

6.  Effectiveness of a Simultaneous rHVT-F(ND) and rHVT-H5(AI) Vaccination of Day-Old Chickens and the Influence of NDV- and AIV-Specific MDA on Immune Response and Conferred Protection.

Authors:  Fabienne Rauw; Eva Ngabirano; Yannick Gardin; Vilmos Palya; Bénédicte Lambrecht
Journal:  Vaccines (Basel)       Date:  2020-09-16

Review 7.  Viral vector-based influenza vaccines.

Authors:  Rory D de Vries; Guus F Rimmelzwaan
Journal:  Hum Vaccin Immunother       Date:  2016-07-25       Impact factor: 3.452

8.  Chickens can durably clear herpesvirus vaccine infection in feathers while still carrying vaccine-induced antibodies.

Authors:  Sylvie Rémy; Gilles Le Pape; David Gourichon; Yannick Gardin; Caroline Denesvre
Journal:  Vet Res       Date:  2020-02-24       Impact factor: 3.683

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.